Long-Term Betaxolol Therapy in Glaucoma Patients With Pulmonary Disease
β Scribed by Weinreb, Robert N.; Cherniack, Reuben; van Buskirk, E. Michael; Drake, Margaret M.
- Book ID
- 127149100
- Publisher
- Elsevier Science
- Year
- 1988
- Tongue
- English
- Weight
- 711 KB
- Volume
- 106
- Category
- Article
- ISSN
- 0002-9394
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
To nine cystic fibrosis patients with chronic bronchopulmonary infection of severely damaged lungs invaded by Pseudomonas aeruginosa, eleven courses of prolonged tobramycin treatment (5 mg/kg/day) for four to 16 weeks were administered. Pulmonary symptoms improved and a better quality of life was ac
Objective. To determine the effects of short-term, maximum-tolerated-dose and long-term, optimum-dose iloprost treatment of severe pulmonary hypertension associated with systemic sclerosis (SSc) and the primary antiphospholipid syndrome (APS). Methods. Three patients with SSc and 2 with APS who had